Titre:
  • Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer
Auteur:Nelson, Joel; Love, William; Chin, Joseph; Saad, Fred; Schulman, Claude; Sleep, Darryl J.; Qian, Jiang; Steinberg, Pascale; Carducci, Michael
Informations sur la publication:Cancer, 113, 9, page (2478-2487)
Statut de publication:Publié, 2008-11
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Atrasentan
Bone alkaline phosphatase
Endothelin
Hormone-refractory prostate cancer
Objective metastatic disease
Prostate-specific antigen doubling time
Note générale:SCOPUS: ar.j
FLWIN
Langue:Anglais
Identificateurs:urn:issn:0008-543X
info:doi/10.1002/cncr.23864
info:scp/55549112219